Family · Pharmaceutical analytical standards
Levetiracetam
An antiepileptic approved in the United States in 1999, used alone or in combination for focal, myoclonic and generalised tonic-clonic seizures; it works by binding the synaptic vesicle protein SV2A. This family brings together the active ingredient, pharmacopoeial impurities, labelled standards, nitrosamines and other impurities.
Did you know?It was synthesised in 1977 within the piracetam family, in the search for a memory drug: it failed in that role but proved surprisingly effective against seizures in an animal model.
No product matches your search.
EDQM standards 6
The official European Pharmacopoeia standards for this family.
Need a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.
